603087.SS

Gan & Lee Pharmaceuticals. 603087.SS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 603087.SS 002223.SZ 600332.SS 688617.SS 300759.SZ 300896.SZ 300347.SZ 600161.SS 300677.SZ 688578.SS
6M 60.53 % 9.47 % -2.71 % 3.08 % 34.06 % -5.28 % 22.06 % -7.98 % 98.98 % 22.15 %
YTD 64.52 % 4.01 % -7.37 % 22.68 % 19.31 % -3.86 % -2.62 % -5.89 % 76.64 % 75.79 %
1Y 40.30 % 6.03 % -11.06 % 21.25 % 6.11 % -22.02 % -18.72 % -13.07 % 63.04 % 88.02 %
3Y 97.38 % 22.96 % -6.15 % 94.75 % -19.73 % -48.65 % -39.81 % 3.65 % 97.06 % 355.25 %
5Y -45.49 % 11.61 % -22.87 % 73.59 % -37.31 % -1.33 % -52.55 % -28.16 % -32.82 % 169.96 %
10Y 6.53 % 53.79 % -9.19 % 73.59 % 512.86 % 25.63 % 132.81 % 135.81 % 689.71 % 169.96 %
From the beginning 6.53 % 2 032.76 % 402.96 % 73.59 % 512.86 % 25.63 % 1 184.65 % 2 903.28 % 689.71 % 169.96 %

Dividend

Gan & Lee Pharmaceuticals.

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

APT Medical Inc.

Pharmaron Beijing Co., Ltd.

Imeik Technology Development Co.,Ltd.

Hangzhou Tigermed Consulting Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd.

Intco Medical Technology Co., Ltd.

Shanghai Allist Pharmaceuticals Co., Ltd.